开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2023-05-29 ms3000000907122076 来自广西

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：预后指标;肝癌预后
经验分享：2023.3.18 submission---under review
2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）
2023.5.08 resubmission---under review
2023.5.23 under review---process in decision
2023.5.28 accept

174 0

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2023-04-05 jiarong 来自湖南省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：属实非常慢的杂志了，8个月到1年起吧

100 0

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2022-08-24 YC1025

审稿速度:12.0 | 投稿命中率:50.0
经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2022-06-20 ms8000001241612634

偏重的研究方向：肿瘤标志物
经验分享：投了将近一个月，现在状态是under review是什么意思？

94 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2020-02-04 Liuying11

我的一天就给了稿号闪电下课 2019-08-04 发表::
投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表:
投稿后一般多久会给稿号啊，现在想看看状态都看不了

闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了

164 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

什么时候需要highlights部分？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

highlights部分的一般要求是什么？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2021-07-24 ms6000001325372637

审稿速度:6.0
偏重的研究方向：肿瘤
经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2021-05-28 ms1000000930252947

请问单基因的生信无验证可以投吗

109 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：预后指标;肝癌预后 经验分享：2023.3.18 submission---under review 2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据） 2023.5.08 resubmission---under review 2023.5.23 under review---process in decision 2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物 经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了闪电下课 2019-08-04 16:38:00 发表: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向：肿瘤 经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]

2021-07-19 147fa11bm80暂无昵称

偏重的研究方向：肿瘤
经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的

120 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务